Dizal’s Zegfrovy Wins US NSCLC Approval, At Lower Dose Than In China

New Once-Daily Oral Option

 
• By Dexter Jie Yan
  
dosing frequency
Zegfrovy is approved with different dosing regimens in the US and China for the same indication. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from New Products